◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Sai Life Sciences Limited (SAILIFE) Financial History

Name: Sai Life Sciences Limited (SAILIFE) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Diagnostics & Research · DATA UPDATED 2026-09-20

Sai Life Sciences Limited (SAILIFE) operates in the Diagnostics & Research industry and is headquartered in Hyderabad, India with about 5,224 employees. Its market capitalization is roughly ₹340 billion. In the fiscal year ended 2026-03-31, SAILIFE reported ₹21.4B in revenue and ₹3.5B in net income.

Sai Life Sciences Limited operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally. It offers medicinal chemistry, pharmacokinetics, clinical and commercial manufacturing, and process development services.

Interactive charts & full statements →

SAILIFE Revenue & Earnings History — Annual Income Statement

Income statement	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Total Revenue	₹21.4B	₹16.6B	₹14.6B	₹12.0B
Gross Profit	₹8.4B	₹6.2B	₹4.9B	₹3.2B
Operating Income (EBIT)	₹4.7B	₹2.7B	₹1.8B	₹768M
Net Income	₹3.5B	₹1.7B	₹828M	₹100M

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

SAILIFE Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-06-30	2025-03-31	2024-12-31
Total Revenue	₹5.5B	₹6.0B	₹5.6B	₹5.0B	₹5.8B	—
Gross Profit	₹2.3B	₹2.5B	₹2.6B	₹1.9B	₹2.6B	—
Operating Income (EBIT)	₹1.0B	₹1.3B	₹1.4B	₹832M	₹1.2B	—
Net Income	₹733M	₹1.0B	₹1.0B	₹604M	₹883M	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

SAILIFE Free Cash Flow History

SAILIFE Balance Sheet History

Balance sheet	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Assets	₹36.3B	₹31.6B	₹22.8B	₹21.9B	—
Total Liabilities	₹11.4B	₹10.3B	₹13.0B	₹13.0B	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive SAILIFE viewer.

SAILIFE Metric Deep Dives

Other Companies in Diagnostics & Research

2359 · WuXi AppTec Co., Ltd. — HK$606 billion
LALPATHLAB · Dr. Lal PathLabs Limited — ₹317 billion
4544 · H.U. Group Holdings, Inc. — JPY 198 billion
VIJAYA · Vijaya Diagnostic Centre Limited — ₹161 billion
SYNGENE · Syngene International Limited — ₹149 billion
4694 · BML, Inc. — JPY 138 billion
METROPOLIS · Metropolis Healthcare Limited — ₹124 billion
2268 · WuXi XDC Cayman Inc. — HK$98 billion

This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी

← SAIL All “S” companies SAIN →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.